Long intergenic noncoding RNA 299 methylation in peripheral blood is a biomarker for triple-negative breast cancer

Aim: To identify DNA methylation biomarkers in peripheral blood samples from triple-negative breast cancer (TNBC) patients. Materials & methods: We conducted an epigenome-wide association study (EWAS): the most promising markers were identified in 233 TNBC case–control pairs (discovery set) and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Lorenzo Bermejo, Justo (VerfasserIn) , Hamann, Ute (VerfasserIn) , Hoheisel, Jörg D. (VerfasserIn) , Garcia Mesa, Karen (VerfasserIn) , González Silos, Rosa (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2019
In: Epigenomics
Year: 2019, Jahrgang: 11, Heft: 1, Pages: 81-93
ISSN:1750-192X
DOI:10.2217/epi-2018-0121
Online-Zugang:Verlag, Volltext: https://doi.org/10.2217/epi-2018-0121
Verlag, Volltext: https://www.futuremedicine.com/doi/10.2217/epi-2018-0121
Volltext
Verfasserangaben:Justo L Bermejo, Guanmengqian Huang, Mehdi Manoochehri, Karen G Mesa, Matthias Schick, Rosa G Silos, Yon-Dschun Ko, Thomas Brüning, Hiltrud Brauch, Wing-Yee Lo, Jörg D Hoheisel & Ute Hamann

MARC

LEADER 00000caa a2200000 c 4500
001 1669472612
003 DE-627
005 20240528110600.0
007 cr uuu---uuuuu
008 190719s2019 xx |||||o 00| ||eng c
024 7 |a 10.2217/epi-2018-0121  |2 doi 
035 |a (DE-627)1669472612 
035 |a (DE-599)KXP1669472612 
035 |a (OCoLC)1341234024 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Lorenzo Bermejo, Justo  |d 1972-  |e VerfasserIn  |0 (DE-588)124754619  |0 (DE-627)706705572  |0 (DE-576)294483632  |4 aut 
245 1 0 |a Long intergenic noncoding RNA 299 methylation in peripheral blood is a biomarker for triple-negative breast cancer  |c Justo L Bermejo, Guanmengqian Huang, Mehdi Manoochehri, Karen G Mesa, Matthias Schick, Rosa G Silos, Yon-Dschun Ko, Thomas Brüning, Hiltrud Brauch, Wing-Yee Lo, Jörg D Hoheisel & Ute Hamann 
264 1 |c 2019 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published online 13 September 2018 
500 |a Gesehen am 19.07.2019 
520 |a Aim: To identify DNA methylation biomarkers in peripheral blood samples from triple-negative breast cancer (TNBC) patients. Materials & methods: We conducted an epigenome-wide association study (EWAS): the most promising markers were identified in 233 TNBC case–control pairs (discovery set) and subsequently validated in an independent validation set (57 TNBC patients and 124 controls). Results: cg06588802 (LINC00299/ID2) showed a higher methylation in TNBC patients compared with controls (discovery set: 3% increase, p-value = 0.0009; validation set: 2% increase, p-value = 0.01). Consistent results at four neighboring methylation probes and the strong negative correlation (rho = -0.93) with LINC00299 expression add plausibility to this result. Conclusion: Hypermethylation of LINC00299 in peripheral blood may constitute a useful circulating biomarker for TNBC. 
700 1 |a Hamann, Ute  |e VerfasserIn  |0 (DE-588)1074024230  |0 (DE-627)830169970  |0 (DE-576)161285090  |4 aut 
700 1 |a Hoheisel, Jörg D.  |d 1958-  |e VerfasserIn  |0 (DE-588)1128674645  |0 (DE-627)883097397  |0 (DE-576)486011305  |4 aut 
700 1 |a Garcia Mesa, Karen  |d 1989-  |e VerfasserIn  |0 (DE-588)1198237988  |0 (DE-627)1680556479  |4 aut 
700 1 |a González Silos, Rosa  |e VerfasserIn  |0 (DE-588)1121144195  |0 (DE-627)874011930  |0 (DE-576)480745471  |4 aut 
773 0 8 |i Enthalten in  |t Epigenomics  |d London [u.a.] : Taylor & Francis Group, 2009  |g 11(2019), 1, Seite 81-93  |h Online-Ressource  |w (DE-627)618334092  |w (DE-600)2537199-X  |w (DE-576)398101248  |x 1750-192X  |7 nnas  |a Long intergenic noncoding RNA 299 methylation in peripheral blood is a biomarker for triple-negative breast cancer 
773 1 8 |g volume:11  |g year:2019  |g number:1  |g pages:81-93  |g extent:13  |a Long intergenic noncoding RNA 299 methylation in peripheral blood is a biomarker for triple-negative breast cancer 
856 4 0 |u https://doi.org/10.2217/epi-2018-0121  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://www.futuremedicine.com/doi/10.2217/epi-2018-0121  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190719 
993 |a Article 
994 |a 2018 
998 |g 1121144195  |a González Silos, Rosa  |m 1121144195:González Silos, Rosa  |d 910000  |d 999701  |e 910000PG1121144195  |e 999701PG1121144195  |k 0/910000/  |k 1/910000/999701/  |p 6 
998 |g 1198237988  |a Garcia Mesa, Karen  |m 1198237988:Garcia Mesa, Karen  |d 910000  |d 999701  |e 910000PG1198237988  |e 999701PG1198237988  |k 0/910000/  |k 1/910000/999701/  |p 4 
998 |g 1128674645  |a Hoheisel, Jörg D.  |m 1128674645:Hoheisel, Jörg D.  |d 50000  |e 50000PH1128674645  |k 0/50000/  |p 11 
998 |g 1074024230  |a Hamann, Ute  |m 1074024230:Hamann, Ute  |d 50000  |e 50000PH1074024230  |k 0/50000/  |p 12  |y j 
998 |g 124754619  |a Lorenzo Bermejo, Justo  |m 124754619:Lorenzo Bermejo, Justo  |d 910000  |d 999701  |e 910000PL124754619  |e 999701PL124754619  |k 0/910000/  |k 1/910000/999701/  |p 1  |x j 
999 |a KXP-PPN1669472612  |e 3495055010 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"role":"aut","family":"Lorenzo Bermejo","display":"Lorenzo Bermejo, Justo","given":"Justo"},{"given":"Ute","family":"Hamann","display":"Hamann, Ute","role":"aut"},{"role":"aut","family":"Hoheisel","display":"Hoheisel, Jörg D.","given":"Jörg D."},{"role":"aut","family":"Garcia Mesa","display":"Garcia Mesa, Karen","given":"Karen"},{"role":"aut","given":"Rosa","display":"González Silos, Rosa","family":"González Silos"}],"physDesc":[{"extent":"13 S."}],"title":[{"title_sort":"Long intergenic noncoding RNA 299 methylation in peripheral blood is a biomarker for triple-negative breast cancer","title":"Long intergenic noncoding RNA 299 methylation in peripheral blood is a biomarker for triple-negative breast cancer"}],"relHost":[{"title":[{"title_sort":"Epigenomics","title":"Epigenomics"}],"physDesc":[{"extent":"Online-Ressource"}],"part":{"issue":"1","year":"2019","extent":"13","pages":"81-93","text":"11(2019), 1, Seite 81-93","volume":"11"},"id":{"zdb":["2537199-X"],"issn":["1750-192X"],"eki":["618334092"]},"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"dateIssuedKey":"2009","publisher":"Taylor & Francis Group ; Future Medicine Ltd.","publisherPlace":"London [u.a.] ; London","dateIssuedDisp":"2009-"}],"pubHistory":["1.2009 -"],"recId":"618334092","note":["Gesehen am 13.05.24"],"disp":"Long intergenic noncoding RNA 299 methylation in peripheral blood is a biomarker for triple-negative breast cancerEpigenomics"}],"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"2019"}],"language":["eng"],"id":{"eki":["1669472612"],"doi":["10.2217/epi-2018-0121"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"name":{"displayForm":["Justo L Bermejo, Guanmengqian Huang, Mehdi Manoochehri, Karen G Mesa, Matthias Schick, Rosa G Silos, Yon-Dschun Ko, Thomas Brüning, Hiltrud Brauch, Wing-Yee Lo, Jörg D Hoheisel & Ute Hamann"]},"note":["Published online 13 September 2018","Gesehen am 19.07.2019"],"recId":"1669472612"} 
SRT |a LORENZOBERLONGINTERG2019